tyrosine has been researched along with Kaposi Sarcoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farzan, MR; Feng, H; Feng, P; Sun, Z | 1 |
| Amaral, MC; Kumar, G; Miles, S; Nel, AE | 1 |
| Albini, A; Benelli, R; Bosia, A; Bussolino, F; Ghigo, D; Graziani, A; Soldi, R | 1 |
| Kishimoto, T; Mori, S; Murakami-Mori, K; Nakamura, S; Taga, T | 1 |
| Ganju, RK; Gill, P; Groopman, JE; Liu, ZY; Munshi, N; Nair, BC | 1 |
| Bonavida, B; Mori, S; Murakami-Mori, K; Nakamura, S | 1 |
| Albini, A; Alitalo, K; Bussolino, F; Cascone, I; Marchiò, S; Pagano, M; Palestro, G; Primo, L; Veikkola, T | 1 |
| Ganju, RK; Gill, PS; Groopman, JE; Munshi, N | 1 |
| Cavallaro, U; Maier, JA; Mariotti, M; Soria, MR; Wu, Z | 1 |
9 other study(ies) available for tyrosine and Kaposi Sarcoma
| Article | Year |
|---|---|
Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation.
Topics: Animals; Chemokine CXCL1; Chemokine CXCL10; Cytokines; Herpesvirus 8, Human; Humans; Mice; NIH 3T3 Cells; Protein Structure, Tertiary; Receptors, G-Protein-Coupled; Sarcoma, Kaposi; Signal Transduction; Tyrosine | 2010 |
Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.
Topics: Acquired Immunodeficiency Syndrome; Benzoquinones; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cell Membrane; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Enzyme Activation; Growth Inhibitors; Humans; Kinetics; Lactams, Macrocyclic; Mitogen-Activated Protein Kinase 1; Oncostatin M; Peptides; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Quinones; Sarcoma, Kaposi; Thymidine; Tumor Cells, Cultured; Tyrosine; Umbilical Veins | 1993 |
Oncostatin M activates phosphatidylinositol-3-kinase in Kaposi's sarcoma cells.
Topics: Antineoplastic Agents; Cytokines; Humans; Oncostatin M; Peptides; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein-Tyrosine Kinases; Sarcoma, Kaposi; Tumor Cells, Cultured; Tyrosine | 1994 |
Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell
Topics: Acquired Immunodeficiency Syndrome; Antigens, CD; Antineoplastic Agents, Hormonal; Cytokine Receptor gp130; Dexamethasone; DNA-Binding Proteins; HIV-1; Humans; Membrane Glycoproteins; Phosphorylation; Sarcoma, Kaposi; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 1997 |
Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Crk-Associated Substrate Protein; Cytoskeletal Proteins; Focal Adhesion Kinase 2; Gene Products, tat; HIV-1; Humans; Oligopeptides; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retinoblastoma-Like Protein p130; Sarcoma, Kaposi; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured; Tyrosine | 1998 |
Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in K
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Antigens, CD; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Cell Division; Dactinomycin; Death Domain Receptor Signaling Adaptor Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Growth Substances; Guanine Nucleotide Exchange Factors; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Sarcoma, Kaposi; Threonine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
Topics: Animals; Cell Division; Cells, Cultured; Chemotaxis; Endothelial Growth Factors; Endothelium, Vascular; Humans; Mice; Mice, Nude; Mutagenesis, Site-Directed; Phosphorylation; Receptor Protein-Tyrosine Kinases; Receptors, Cell Surface; Recombinant Proteins; Sarcoma, Kaposi; Transplantation, Heterologous; Tumor Cells, Cultured; Tyrosine; Umbilical Veins; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 1999 |
c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells.
Topics: Cell Adhesion; Cell Adhesion Molecules; Cell Division; Cytoskeletal Proteins; Endothelial Growth Factors; Enzyme Activation; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Growth Inhibitors; Humans; Lymphokines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Pyrazoles; Pyrimidines; Sarcoma, Kaposi; src-Family Kinases; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Differential response to Tat and FGF-2 of two novel clonal populations derived from murine Kaposi-like lesions developing in Tat transgenic mice.
Topics: Animals; Blotting, Western; Cell Division; Cell Line; Cell Movement; Cells, Cultured; Cloning, Molecular; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibroblast Growth Factor 2; Gene Products, tat; Immunohistochemistry; Mice; Mice, Transgenic; Microscopy, Fluorescence; Phosphorylation; Precipitin Tests; Sarcoma, Kaposi; Signal Transduction; Tyrosine; Urokinase-Type Plasminogen Activator | 2002 |